MoneyWorks4Me

Dr Reddys Laboratories informs about disclosure

20 Mar 2025 Evaluate
Dr Reddys Laboratories has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satish Reddy Kallam & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1788.00
Dr. Reddys Labs. 1198.30
Cipla 1335.70
Lupin 2012.65
Zydus Lifesciences 1143.70
View more..